New report from Access to Medicine Foundation shows what pharma companies can do to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance

AMSTERDAM, May 23, 2024 /PRNewswire/ -- The race to create replacement antibiotics and antifungals to combat superbugs is falling dangerously short, putting people across the world at risk.

Related Keywords

South Africa ,Mexico ,India ,Thailand ,China ,Amsterdam ,Noord Holland ,Netherlands ,Jayasreek Iyer , ,Pfizer ,Assembly Meeting ,Access To Medicine Foundation ,Medicine Foundation ,High Level Meeting ,Ihr Portfolio ,